New Issue: Antigenics completes $10 million private placement of stock, warrants

By Devika Patel

Knoxville, Tenn., Aug. 3 - Antigenics Inc. settled a $10 million private placement of shares on July 30, according to an 8-K filed Monday with the Securities and Exchange Commission.

The company sold 5 million shares at $2.00 apiece. Investors also received six-month warrants for up to 2.5 million common shares, exercisable at $2.00, and four-year warrants for up to 2,173,900 additional shares, exercisable at $2.30.

Rodman & Renshaw, LLC was the agent.

Antigenics is a New York-based biotechnology company with a focus on cancers and infectious diseases.

Issuer:	Antigenics Inc.
Issue:	Common shares
Amount:	$10 million
Shares:	5 million
Price:	$2.00
Warrants:	For 4,673,900 shares
Warrant expiration:	Four years (for up to 2,173,900 shares), six months (for 2.5 million shares)
Warrant strike price:	$2.30 (for up to 2,173,900 shares), $2.00 (for 2.5 million shares)
Agent:	Rodman & Renshaw, LLC
Settlement date:	July 30
Stock symbol:	Nasdaq: AGEN
Stock price:	$2.58 at close July 30
Market capitalization:	$188 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.